BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19535162)

  • 1. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort.
    Miyamoto Y; Morisaki H; Yamanaka I; Kokubo Y; Masuzaki H; Okayama A; Tomoike H; Nakao K; Okamura T; Yoshimasa Y; Morisaki T
    Diabetes Res Clin Pract; 2009 Aug; 85(2):132-8. PubMed ID: 19535162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Després JP; Tchernof A; Vohl MC
    Obes Res; 2004 Oct; 12(10):1570-5. PubMed ID: 15536220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK; Nielsen MP; Richelsen B; Bruun JM; Flyvbjerg A; Pedersen SB
    Obesity (Silver Spring); 2008 Apr; 16(4):731-5. PubMed ID: 18379559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.
    Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
    Int J Obes (Lond); 2012 Dec; 36(12):1558-63. PubMed ID: 22310475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population.
    Gandhi K; Adhikari P; Basu A; Achappa B
    Metab Syndr Relat Disord; 2013 Dec; 11(6):397-402. PubMed ID: 23869418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome.
    Schnackenberg CG
    Curr Opin Investig Drugs; 2008 Mar; 9(3):295-300. PubMed ID: 18311666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-hydroxysteroid dehydrogenase type 1 gene expression is increased in ascending aorta tissue of metabolic syndrome patients with coronary artery disease.
    Atalar F; Vural B; Ciftci C; Demirkan A; Akan G; Susleyici-Duman B; Gunay D; Akpinar B; Sagbas E; Ozbek U; Buyukdevrim AS
    Genet Mol Res; 2012 Aug; 11(3):3122-32. PubMed ID: 23007990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating 11beta-hydroxysteroid dehydrogenase type 1 mRNA and cardiovascular risk factors.
    Al Bakir M; Butt AN; Swaminathan R
    Ann N Y Acad Sci; 2008 Aug; 1137():283-9. PubMed ID: 18837961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome.
    Tomlinson JW; Stewart PM
    Nat Clin Pract Endocrinol Metab; 2005 Dec; 1(2):92-9. PubMed ID: 16929377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.
    Cooper MS; Stewart PM
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4645-54. PubMed ID: 19837912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.
    Boyle CD; Kowalski TJ
    Expert Opin Ther Pat; 2009 Jun; 19(6):801-25. PubMed ID: 19456274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes in placentas of small-for-gestational-age neonates.
    Struwe E; Berzl GM; Schild RL; Beckmann MW; Dörr HG; Rascher W; Dötsch J
    Am J Obstet Gynecol; 2007 Jul; 197(1):43.e1-6. PubMed ID: 17618751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
    Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.